v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 28, 2026
Mar. 29, 2025
Operating activities:    
Net income (loss) $ 11,210 $ (4,787)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Stock-based compensation 20,605 19,745
Depreciation and amortization 4,376 4,271
Deferred income taxes 1,274 (1,459)
Net accretion of available-for-sale securities (435) (1,144)
Changes in operating assets and liabilities:    
Accounts receivable, net (17,405) 3,810
Inventory (20,889) 1,891
Prepaid expenses and other assets 804 2,808
Accounts payable 26,243 3,486
Accrued liabilities (10,298) (14,086)
Deferred revenue 232 3,158
Other long-term liabilities (1,083) (481)
Net cash provided by operating activities 14,634 17,212
Investing activities    
Purchases of property and equipment (8,118) (4,310)
Purchases of marketable securities (10,038) (36,856)
Sales of marketable securities 24,621 0
Maturities of marketable securities 41,388 52,154
Net cash provided by investing activities 47,853 10,988
Financing activities:    
Proceeds from common stock issuances related to employee benefit plans 19,999 10,845
Repurchases of common stock (170,869) (39,974)
Net cash used in financing activities (150,870) (29,129)
Effect of exchange rate changes on cash and cash equivalents (102) 67
Net decrease in cash and cash equivalents (88,485) (862)
Cash and cash equivalents at beginning of period 143,086 43,162
Cash and cash equivalents at end of period $ 54,601 $ 42,300

Source

10-Q XBRL Zip